Tag: AD

Clinical Trials, Research and Development

Trial raises hopes for simple Alzheimer’s blood test

January 23, 2024

Via: Pharmaphorum

Testing a person’s blood for a protein called phosphorylated tau could provide a means of large-scale screening for Alzheimer’s disease (AD), according to a new study. The immunoassay – which has been developed by California biotech ALZpath – focuses on […]


AstronauTx completes £48m series A financing for Alzheimer’s disease

October 12, 2023

Via: Pharma Times

AstronauTx has announced the completion of a £48m Series A financing to create new treatments for Alzheimer’s disease (AD). As part of the investment led by the Novartis Venture Fund, the financing was supported by several global venture investors, including […]